NEWS
2011 Winter Meeting Original Communication Winner
Congratulations to Orla Power (WP1), University of Limerick who presented the best Poster Communication entitled A comparison of the insulinotropic and enterogastric response to ingestion of an equiva
Professor David Kerins
Contact Details
School of Medicine
University College Cork
Tel: +353-21-4901575
Email: d.kerins@ucc.ie
Academic Background
David Kerins received a BSc in Physiology in 1981, and an MB, BAO, BCh from University College Cork in 1984. He completed internal medicine training at Cork University Hospital in 1987. This was followed by sequential fellowships in Clinical Pharmacology and in Clinical Cardiology at Vanderbilt University, Nashville TN. These fellowships had the support of a Merck Sharp and Dohme International fellowship in Clinical Pharmacology and a Fellowship award from the Pharmaceutical Manufacturers Association Foundation and resulted in the award of an M.D. from UCC. He then spent one year as a special lecturer in the Department of Medicine and Experimental Therapeutics at University College Dublin, with the support of an award from the Health Research Board. He was appointed to the faculty of Vanderbilt University Medical Center and as a staff physician at Nashville Veterans Affairs in 2003. He was subsequently promoted to become an Associate Professor of Medicine and Chief of the Cardiology Section at Nashville VA. He was appointed as Associate Professor of Therapeutics at University College Cork and Consultant Physician at Mercy University Hospital in 2006. His current appointment as Dean of the School of Medicine began in 2007.
Research Interests
Prof. Kerins is interested in anti-platelet and anti-thrombotic therapy, vascular biology with a particular focus on the rennin-angiotensin and fibrinolytic pathways, and non-invasive cardiac imaging. He is a fellow of the American Heart Association, the American College of Cardiology, the European Society of Cardiology and the American Society of Echocardiography. He coordinates work programme 6d at FHI, which investigates the ability of milk bioactives to improve the prothrombotic and endothelial dysfunction that are central to the metabolic syndrome.
Publications
Some of Prof. Kerins' publications include:
The PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine 2003; 348: 1425-34.
The Warfarin and Antiplatelet Therapy in Heart Failure Trial (WATCH): rationale, design, and baseline patient characteristics. Journal of Cardiac Failure 2004:10: 101-12.
Wagner C., Stone W.J., Koury M.J., Dupont W.D., Kerins D.M., S-adenosylhomocysteine is a more sensitive indicator of renal insufficiency than homocysteine. Nutrition Research 2004; 24: 487–494
O'Sullivan J., Kerins D., Vaughan C. Massive thrombus in the aortic arch: A 59-year-old lady with an unknown familial predisposition to vascular thrombosis. European Journal of Echocardiography 2008; 9:179-80
O'Sullivan J., Kerins D., McEneaney P., Vaughan C. Soft tissue neoplasm invading the heart with associated thrombus in a 74-year-old man. European Journal of Echocardiography 2008; 9:143-44